Galapagos reported EUR4.97B in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
AstraZeneca AZN:LN USD 94.18B 2.39B
Biogen BIIB:US USD 24.85B 227.2M
Genmab GEN:DC DKK 30.69B 3.21B
Gilead Sciences GILD:US USD 63.17B 614M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
Hikma Pharmaceutical HIK:LN USD 4.75B 375M
Merck MRK:GR EUR 50.93B 2.22B
Novartis NOVN:VX USD 117.45B 1.01B
Roche Holding ROG:VX 86.74B 5.58B